OneCell Diagnostics is now 1Cell.Ai
OneCell Diagnostics is now 1Cell.Ai
We understand that every stakeholder in cancer care—from clinicians to researchers to biopharma—faces unique challenges. Our AI-driven, single-cell multi-omics platform delivers customizable, real-time insights designed to meet the needs of each audience.
Empowering Real-Time, Personalized Cancer Care
We provide clinicians with non-invasive, advanced diagnostic tools to detect cancer earlier, guide treatment decisions, and monitor patient progress.
Key Benefits:
Accelerating Drug Development & Oncology Research
Our technology supports biopharma and research partners with deep molecular insights and scalable data solutions to advance clinical trials, biomarker discovery, and targeted therapies.
Key Benefits:
Personalized Insights for Better Outcomes
Our AI-powered, single-cell diagnostics provide cancer patients with earlier detection, more precise treatment planning, and continuous monitoring—empowering clinicians to deliver care tailored to each patient’s unique cancer profile.
Key Benefits:
Earlier diagnosis through real-time liquid biopsy
More personalized treatment strategies
Continuous monitoring of disease progression
Access to insights based on advanced single-cell and multi-omics data
Tailored AI Models & Data Platforms for Unique Oncology Challenges
For partners seeking bespoke solutions, we offer custom AI algorithm development and multi-omics data integration to meet specific research or clinical goals.
Key Capabilities:
Empowering clinicians with real-time molecular data to guide diagnosis and treatment.
Providing researchers and labs with unprecedented resolution to study tumor biology and heterogeneity.
Accelerating biomarker identification and validation for biopharma and clinical trials.
Fostering a unified ecosystem where clinicians, researchers, and partners leverage shared insights to improve patient outcomes.
